Blood flow failure as a major determinant in the antitumor action of flavone acetic acid
- PMID: 2733044
- DOI: 10.1093/jnci/81.13.1005
Blood flow failure as a major determinant in the antitumor action of flavone acetic acid
Abstract
Some investigators have suggested that the marked activity of flavone acetic acid (FAA) against advanced solid tumors in mice results from an indirect effect. This study indicates that the critical effect of FAA is irreversible inhibition of tumor blood flow. Perfusion of sc Colon 38 tumors, assessed with H33342 as a fluorescent stain for functional blood vessels, was reduced to 50% of controls within 3 hours of an ip injection of 1.2 mmol of FAA/kg and was completely inhibited by 24 hours. A double-label fluorescence technique demonstrated a significant decrease in blood flow in both sc Colon 38 and im EMT-6/Ak tumors as early as 15 minutes after iv treatment with 1.2 mmol of FAA/kg, with progressively enlarging zones of perfusion failure. The rate of cell death in totally ischemic EMT-6 tumors was shown to be sufficiently rapid to represent a major component of the observed antitumor effect of FAA if the flavonoid acts via inhibition of blood flow. Further, avascular EMT-6/Ak multicellular spheroids growing in the mouse peritoneum are relatively resistant to killing by FAA administered iv or ip, despite extensive infiltration with host immune cells. These results indicate that inhibition of tumor blood flow by FAA is a necessary component of its antitumor activity against solid tumors.
Similar articles
-
Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.J Natl Cancer Inst. 1989 Feb 1;81(3):216-20. doi: 10.1093/jnci/81.3.216. J Natl Cancer Inst. 1989. PMID: 2911084
-
The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.Br J Cancer. 1990 Aug;62(2):231-7. doi: 10.1038/bjc.1990.266. Br J Cancer. 1990. PMID: 2386739 Free PMC article.
-
Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect.J Natl Cancer Inst. 1988 Apr 20;80(4):241-5. doi: 10.1093/jnci/80.4.241. J Natl Cancer Inst. 1988. PMID: 3351960
-
Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.Cancer Chemother Pharmacol. 1987;19(1):6-10. doi: 10.1007/BF00296246. Cancer Chemother Pharmacol. 1987. PMID: 3545524 Review.
-
Flavone acetic acid--from laboratory to clinic and back.Anticancer Drugs. 1993 Feb;4(1):3-17. doi: 10.1097/00001813-199302000-00001. Anticancer Drugs. 1993. PMID: 8457711 Review.
Cited by
-
A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid.Cancer Chemother Pharmacol. 1992;29(5):354-60. doi: 10.1007/BF00686003. Cancer Chemother Pharmacol. 1992. PMID: 1551173
-
Divergent effects of flavone acetic acid on established versus developing tumour blood flow.Br J Cancer. 1991 Jun;63(6):889-92. doi: 10.1038/bjc.1991.195. Br J Cancer. 1991. PMID: 1712621 Free PMC article.
-
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.Drug Metab Lett. 2011 Apr;5(2):73-84. doi: 10.2174/187231211795305221. Drug Metab Lett. 2011. PMID: 21457135 Free PMC article.
-
Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.Br J Cancer. 1992 Sep;66(3):579-82. doi: 10.1038/bjc.1992.317. Br J Cancer. 1992. PMID: 1520597 Free PMC article. Clinical Trial.
-
Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid.Br J Cancer. 1990 Dec;62(6):932-4. doi: 10.1038/bjc.1990.412. Br J Cancer. 1990. PMID: 2257222 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous